Todd C Cooper, a director at $GXO, bought 6,000 shares of the company on 11-28-2025 for an estimated $303,540. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 148.5%. Following this trade, they now own 10,040 shares of this class of $GXO stock.
$GXO Insider Trading Activity
$GXO insiders have traded $GXO stock on the open market 1 times in the past 6 months. Of those trades, 1 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $GXO stock by insiders over the last 6 months:
- TODD C COOPER purchased 6,000 shares for an estimated $303,540
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$GXO Hedge Fund Activity
We have seen 206 institutional investors add shares of $GXO stock to their portfolio, and 252 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- AXA S.A. removed 1,000,759 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $52,930,143
- VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P. removed 987,350 shares (-59.0%) from their portfolio in Q3 2025, for an estimated $52,220,941
- BALYASNY ASSET MANAGEMENT L.P. added 780,431 shares (+1511.4%) to their portfolio in Q3 2025, for an estimated $41,276,995
- FIL LTD removed 776,227 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $41,054,646
- NORGES BANK removed 730,512 shares (-57.5%) from their portfolio in Q2 2025, for an estimated $35,575,934
- CITADEL ADVISORS LLC added 675,097 shares (+84.6%) to their portfolio in Q3 2025, for an estimated $35,705,880
- PARSIFAL CAPITAL MANAGEMENT, LP added 647,457 shares (+77.5%) to their portfolio in Q3 2025, for an estimated $34,244,000
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$GXO Analyst Ratings
Wall Street analysts have issued reports on $GXO in the last several months. We have seen 10 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- JP Morgan issued a "Overweight" rating on 11/06/2025
- Wells Fargo issued a "Overweight" rating on 10/06/2025
- Morgan Stanley issued a "Overweight" rating on 10/06/2025
- Goldman Sachs issued a "Buy" rating on 09/24/2025
- UBS issued a "Buy" rating on 08/07/2025
- Susquehanna issued a "Positive" rating on 08/07/2025
- Oppenheimer issued a "Outperform" rating on 08/07/2025
To track analyst ratings and price targets for $GXO, check out Quiver Quantitative's $GXO forecast page.
$GXO Price Targets
Multiple analysts have issued price targets for $GXO recently. We have seen 11 analysts offer price targets for $GXO in the last 6 months, with a median target of $62.0.
Here are some recent targets:
- Brian Ossenbeck from JP Morgan set a target price of $67.0 on 11/06/2025
- Ravi Shanker from Morgan Stanley set a target price of $58.0 on 10/06/2025
- Christian Wetherbee from Wells Fargo set a target price of $65.0 on 10/06/2025
- Thomas Wadewitz from UBS set a target price of $63.0 on 10/03/2025
- Patrick Creuset from Goldman Sachs set a target price of $68.0 on 09/24/2025
- Scott Schneeberger from Oppenheimer set a target price of $62.0 on 08/07/2025
- Bascome Majors from Susquehanna set a target price of $60.0 on 08/07/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
.jpeg)